Best practices for the development, scale-up, and post-approval change control of IR and MR dosage forms in the current quality-by-design paradigm

AAPS PharmSciTech. 2014 Jun;15(3):665-93. doi: 10.1208/s12249-014-0087-x. Epub 2014 Mar 1.

Abstract

In this whitepaper, the Manufacturing Technical Committee of the Product Quality Research Institute provides information on the common, best practices in use today in the development of high-quality chemistry, manufacturing and controls documentation. Important topics reviewed include International Conference on Harmonization, in vitro-in vivo correlation considerations, quality-by-design approaches, process analytical technologies and current scale-up, and process control and validation practices. It is the hope and intent that this whitepaper will engender expanded dialog on this important subject by the pharmaceutical industry and its regulatory bodies.

Publication types

  • Guideline
  • Review

MeSH terms

  • Animals
  • Benchmarking / standards*
  • Chemistry, Pharmaceutical / standards
  • Delayed-Action Preparations / standards
  • Drug Approval
  • Drug Industry / methods
  • Drug Industry / standards*
  • Excipients / chemistry
  • Excipients / standards
  • Humans
  • Pharmaceutical Preparations / administration & dosage
  • Pharmaceutical Preparations / chemistry
  • Pharmaceutical Preparations / standards*
  • Pharmacokinetics
  • Quality Control
  • Risk Assessment
  • Solubility
  • Technology, Pharmaceutical / methods
  • Technology, Pharmaceutical / standards*
  • Toxicology / standards
  • Vereinigte Staaten
  • United States Food and Drug Administration

Substances

  • Delayed-Action Preparations
  • Excipients
  • Pharmaceutical Preparations